Survey of poliovirus antibodies during the final stage of polio eradication in Egypt

Vaccine

Volumn 25, Issue 27, 2007, Pages 5062-5070

  El Sayed, Nasr ^a   Al Jorf, Samir ^b   Hennessey, Karen A ^d   Salama, Maha ^c   Watkins, Margaret A ^d   Abdelwahab, Jalaa A ^e   Pallansch, Mark A ^d   Gary, Howard ^d   Wahdan, Mohamed Helmy ^e   Sutter, Roland W ^b  

^a MINISTRY OF HEALTH   (Egypt)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c VACSERA   (Egypt)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e WHO   (Egypt)

Author keywords

Poliomyelitis; Serosurvey; Vaccine

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ARTICLE; CONTROLLED STUDY; DIARRHEA; EDUCATION; EGYPT; FEMALE; HUMAN; IMMUNITY; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALE; MOTHER; POLIOMYELITIS; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; SEROLOGY; SEROPREVALENCE; SERUM; SOCIAL STATUS; STUNTING SYNDROME; UNIVARIATE ANALYSIS;

ANTIBODIES, VIRAL; BLOOD SPECIMEN COLLECTION; DATA INTERPRETATION, STATISTICAL; DISEASE RESERVOIRS; EGYPT; FEMALE; HUMANS; INFANT; MALE; POLIOMYELITIS; POLIOVIRUS; RISK FACTORS; SAMPLE SIZE; SEROEPIDEMIOLOGIC STUDIES; TERMINOLOGY;

EID: 34250207744     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.022     Document Type: Article

References (26)

1. Paul J.R. A history of poliomyelitis (1971), Yale University Press, New Haven
2. Aylward R.B., Mansour E., Oon E.S.A., et al. The eradication of poliomyelitis in Egypt: critical factors affecting progress to date. J Infect Dis 175 Suppl. 1 (1997) S56-S61
3. Yang C.F., Naguib T., Yang S.J., et al. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol 77 (2003) 8366-8377
4. WHA. Global Eradication of Poliomyelitis. Resolutions of the 41st World Health Assembly. World Health Organization, 1988 (Resolution 41.28).
5. Hull H.F., Ward N.A., Hull B.P., Milstien J.B., and de Quadros C. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 343 (1994) 1131-1137
6. WHO. Progress towards poliomyelitis eradication, Egypt, 2001. Wkly Epidemiol Rec 77 (2002) 70-74
7. WHO. Progress towards poliomyelitis eradication in Egypt, 2002. Wkly Epidemiol Rec 78 (2003) 90-94
8. El Bassioni L., Barakat I., Nasr E., et al. Prolonged detection of indigenous wild polioviruses in sewage from communities in Egypt. Am J Epidemiol 158 (2003) 807-815
9. Sutter R.W., and Maher C. Mass vaccination: global aspects-progress and obstacles. Current Topics in Microbiology & Immunology (2006), Springer Verlag, Berlin, Germany pp. 196-220
10. WHO. Progress towards poliomyelitis eradication in Egypt, January 2003 to July 2004. Wkly Epidemiol Rec 79 (2004) 316-319
11. Sutter R.W., Kew O.M., and Cochi S.L. Poliovirus vaccine-live. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th ed. 25 (2003), W.B. Saunders Company, Philadelphia, PA 651-705
12. Library of Congress. Federal Research Division. Country studies/area handbook series (http://countrystudies.us/Egypt/55.htm accessed 31 May 2006).
13. Paul J.R., Melnick J.L., Barnett V.H., and Goldblum N. A survey of neutralizing antibodies to poliomyelitis virus in Cairo. Am J Hygiene 55 (1952) 402-413
14. Albrecht P., van Steenis G., van Wezel A.L., and Salk J. Standardization of the poliovirus neutralization antibody tests. Rev Infect Dis 6 Suppl. 2 (1984) S540-S544
15. Sutter R.W., Pallansch M.A., Sawyer L.A., Cochi S.L., and Hadler S.C. Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination. Ann NY Acad Sci 754 (1995) 289-299
16. Finney D.J. Statistical methods in biologic assays. second ed. (1964), Hafner Publishing, New York, NY 524-530
17. Dean A.G., Arner T.G., Sangam S., Sunki G.G., Friedman R., Lantinga M., et al. Epi Info 2000, a database and statistics program for public health professionals for use on Windows 95, 98, NT and 2000 computers (2000), Centers for Disease Control and Prevention, Atlanta, GA, USA
18. WHO Working Group. Use and interpretation of anthropometric indicators of nutritional status. Bull WHO 64 (1986) 929-941
19. Sutter R.W., Patriarca P.A., Suleiman A.J.M., Pallansch M.A., Brogan S., Malankar P.G., et al. Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine. Int J Epidemiol 22 (1993) 936-944
20. Patriarca P.A., Wright P.F., and John T.J. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 13 (1991) 926-939
21. Posey D.L., Linkins R.W., Couto Oliveira M.J., Monteiro D., and Patriarca P.A. The effect of diarrhea on oral poliovirus vaccine failure in Brazil. J Infect Dis 175 Suppl. 1 (1997) S258-S263
22. Myaux J.A., Unicomb L., Besser R.E., et al. Effect of diarrhea on the humoral response to oral polio vaccination. Pediatric Infect Dis J 15 (1996) 204-209
23. Domök I., Balayan M.S., Fayinka O.A., et al. Factors affecting the efficacy of live poliovirus vaccine in warm climates. Efficacy of type 1 Sabin vaccine administered together with antihuman gamma-globulin horse serum to breast-fed and artificially fed infants in Uganda. Bull World Health Org 51 (1974) 333-347
24. Schwartz T.A., Skalska P., Gerichter C.B., and Cockburn W.C. Non-polio virus interference with oral polio vaccine immunization: possible influence of physical climate and socioeconomic status. Adv Exp Med Biol 31 (1972) 237-240
25. Mahmoud A.A.M., Iman I.Z.E., Abozid S.S., El-Mished A.M., and Mitkis F.A. The influence of bacillary dysentery on the efficiency of oral poliovaccine in Egypt. Gaz Egypt Paediatr Assoc 24 (1976) 82-91
26. WHO. Resurgence of wild poliovirus type 1 transmission and effect of importation into polio-free countries, 2002-2005. Wkly Epidemiol Rec 81 (2006) 63-68